Professor Baowen Dong is an expert member of Sichuan University Teaching Evaluation Council since August 2001. Prior to his current role, he served as a professor, research fellow, director of teaching and researching office, and department head at Sichuan University. Mr. Dong graduated from Xi'an University of Science and Technology in 1966.
"Mei Tsui Heung has been a valuable director of China Pharma and we appreciate her contribution to our Company and we wish her well in her future endeavors," said Ms. Zhilin Li, president and CEO of China Pharma.
"I would like to welcome Mr. Bennett, Mr. Zhang and Mr. Dong to our Board of Directors. Having a group of directors with a diverse set of skills to serve on our board creates a deep knowledge base for the company to tap into. Mr. Bennett's extensive experience in accounting and corporate governance, Mr. Zhang's business acumen and proven track record in developing high-growth companies, and Professor Dong's academic knowledge in research and development will be particularly valuable for our business. Our newly formed audit committee will be an important element to build a strong foundation in corporate governance and financial integrity, while enabling us to pursue a listing on a major exchange this year. We look forward to their participation on the board in contributing to our future growth and success," concluded Ms. Li.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic
and brand bio-pharmaceutical products in China that treat a wide range of
conditions, including infections, hepatitis, cardiovascular and CNS
diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co.,
Ltd (Helpson), a specialty pharmaceutical company headquartered in Haikou
City, Hainan province in China, is a wholly owned subsidiary of
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved